The burden and contemporary epidemiology of sepsis in children
Бремя и современная эпидемиология сепсиса у детей
2024-08-12
SCID: 54.1/yqy6jy5v
Discuss with AI
Global Burden of DiseasePhoenix criteriapaediatric sepsispost-sepsis syndromesepsis epidemiology
Figures from the paper
Abstract (AI)
Sepsis is a dysregulated host response to infection that leads to life-threatening organ dysfunction. Half of the 50 million people affected by sepsis globally every year are neonates and children younger than 19 years. This burden on the paediatric population translates into a disproportionate impact on global child health in terms of years of life lost, morbidity, and lost opportunities for children to reach their developmental potential. This Series on paediatric sepsis presents the current state of diagnosis and treatment of sepsis in children, and maps the challenges in alleviating the burden on children, their families, and society. Drawing on diverse experience and multidisciplinary expertise, we offer a roadmap to improving outcomes for children with sepsis. This first paper of the Series is a narrative review of the burden of paediatric sepsis from low-income to high-income settings. Advances towards improved operationalisation of paediatric sepsis across all age groups have facilitated more standardised assessment of the Global Burden of Disease estimates of the impact of sepsis on child health, and these estimates are expected to gain further precision with the roll out of the new Phoenix criteria for sepsis. Sepsis remains one of the leading causes of childhood morbidity and mortality, with immense direct and indirect societal costs. Although substantial regional differences persist in relation to incidence, microbiological epidemiology, and outcomes, these cannot be explained by differences in income level alone. Recent insights into post-discharge sequelae after paediatric sepsis, ranging from late mortality and persistent neurodevelopmental impairment to reduced health-related quality of life, show how common post-sepsis syndrome is in children. Targeting sepsis as a key contributor to poor health outcomes in children is therefore an essential component of efforts to meet the Sustainable Development Goals.
Key Findings
1
Improved operationalisation across paediatric age groups has enabled more standardised assessment of sepsis burden; the Phoenix criteria are expected to further refine estimates.
2
Incidence, microbiological patterns, and outcomes vary substantially between regions, and these differences cannot be explained by income level alone.
3
Paediatric sepsis is a leading cause of childhood morbidity and mortality, imposing substantial direct and indirect societal costs and years of life lost.
4
Post-sepsis syndrome is common in children, including late mortality, persistent neurodevelopmental impairment, and reduced health-related quality of life.
5
Sepsis affects approximately 50 million people globally each year, with neonates and children under 19 comprising half of those affected.
Research Object
paediatric sepsis
Research Subject
the burden and contemporary epidemiology of paediatric sepsis, including incidence, microbiological patterns, outcomes, and post-sepsis sequelae across income settings
Publication Details
Publication Date
2024-08-12
Journal
Publisher
ISSN
Cited by
142
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai6
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)2016
Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study2020
Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 20192022
International Consensus Criteria for Pediatric Sepsis and Septic Shock2024
Development and Validation of the Phoenix Criteria for Pediatric Sepsis and Septic Shock2024
Criteria for Pediatric Sepsis—A Systematic Review and Meta-Analysis by the Pediatric Sepsis Definition Taskforce*2021